Related Experiment Videos
[The comet assay: principles of the method and clinical utilization]
B Novotná1, R Neuwirtová, V Blazková
1Ustav experimentální medicíny AV CR, Praha. novotna@biomed.cas.cz
Casopis Lekaru Ceskych
|December 6, 2003
Summary
The comet assay detects DNA damage and apoptosis in myelodysplastic syndrome (MDS). This method shows increased DNA breaks in certain MDS types, aiding diagnosis and monitoring treatment efficacy.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Context:
- The comet assay is a global standard for studying DNA damage, repair, and apoptosis.
- Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis and increased risk of transformation to acute myeloid leukemia.
- Apoptosis, or programmed cell death, plays a critical role in maintaining hematopoietic homeostasis.
Purpose:
- To introduce the comet assay principle and its clinical applications to the medical community.
- To present the initial experience of using the comet assay for detecting apoptosis in bone marrow cells of MDS patients.
- To evaluate the utility of the comet assay in diagnosing and monitoring MDS.
Summary:
- The alkaline comet assay was performed on bone marrow aspirates from 6 MDS patients and 7 controls.
- Quantification of DNA fragmentation using an Image Analysis System revealed a significantly elevated number of cells with high DNA breaks in MDS patients with RA and RARS diagnoses compared to controls.
- A patient in the proliferative stage (MDS-CMML-->AML) showed a decreased frequency of apoptotic cells, below the control level.
Impact:
- The comet assay is a simple, cost-effective technique for clinical hematology.
- This method can aid in specifying MDS diagnoses and monitoring disease progression and therapy effectiveness.
- The comet assay's applicability extends to other diseases involving an imbalance between proliferation and apoptosis.